Personnel Information

写真a

YOKOYAMA Minato


Job title

Visiting Lecturer

Birth date

1976

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Doctor's Course, 2009, Completed

Degree 【 display / non-display

  • PhD

Campus Career 【 display / non-display

  • 2014.12
    -
    2016.12
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Assistant Professor
  • 2014.04
    -
    2014.12
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Assistant Professor
  • 2014.04
    -
    Now
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Assistant Professor
  • 2017.01
    -
    2017.03
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2017.04
    -
    2019.10
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2019.11
    -
    2020.03
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2020.04
    -
    2021.07
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Department of Insured Medical Care Management, Junior Associate Professor
  • 2021.08
    -
    2021.09
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Department of Insured Medical Care Management, Associate Professor
  • 2021.10
    -
    2022.12
    Tokyo Medical and Dental University, Tokyo Medical and Dental University, Department of Insured Medical Care Management, Associate Professor
  • 2023.01
    -
    2023.04
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Public Health, Department of Insured Medical Care Management, Visiting Lecturer
  • 2023.05
    -
    2024.04
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Public Health, Department of Insured Medical Care Management, Visiting Lecturer
  • 2024.05
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Public Health, Department of Insured Medical Care Management, Visiting Lecturer

▼display all

Academic Society Affiliations 【 display / non-display

  • Japanese Urological Association

Research Areas 【 display / non-display

  • Urology

 

Published Papers & Misc 【 display / non-display

  1. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; ( PubMed, DOI )

  2. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

  3. Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

  4. Shumpei Yamamoto, Hiroshi Fukushima, Shohei Fukuda, Sho Uehara, Yosuke Yasuda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol. 2022.08; 18 (4): 410-418. ( PubMed, DOI )

  5. Shunya Matsumoto, Yuki Arita, Soichiro Yoshida, Hiroshi Fukushima, Koichiro Kimura, Ichiro Yamada, Hajime Tanaka, Fumiko Yagi, Minato Yokoyama, Yoh Matsuoka, Mototsugu Oya, Ukihide Tateishi, Masahiro Jinzaki, Yasuhisa Fujii. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdom Radiol (NY). 2022.06; 47 (6): 2178-2186. ( PubMed, DOI )

  6. Yoh Matsuoka, Sho Uehara, Kazuma Toda, Hiroshi Fukushima, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Kazunori Kihara, Yasuhisa Fujii. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urol Oncol. 2022.04; 40 (4): 161.e15-161.e23. ( PubMed, DOI )

  7. Yusuke Uchida, Soichiro Yoshida, Yuki Arita, Hiroki Shimoda, Koichiro Kimura, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Masahiro Jinzaki, Yasuhisa Fujii. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel). 2022.03; 12 (4): ( PubMed, DOI )

  8. Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Koichiro Kimura, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers (Basel). 2022.01; 14 (3): 567. ( PubMed, DOI )

  9. Tanaka H*, Fukuda S, Kimura K, Fukawa Y, Yamamoto K, Fukushima H, Moriyama S, Yasuda Y, Uehara S, Waseda Y, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Tateishi U, Campbell SC, Fujii Y. . Defining tumour shape irregularity for preoperative risk stratification of clinically localised renal cell carcinoma Eur Urol Open Sci. . 2022;

  10. Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel). 2022;

  11. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

  12. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy Int J Urol. 2022;

  13. Yudai Ishikawa, Hiroshi Fukushima, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Yasuyuki Sakai, Yukihiro Otsuka, Ryoji Takazawa, Masataka Yano, Tetsuro Tsukamoto, Tetsuo Okuno, Akira Noro, Katsushi Nagahama, Shigeyoshi Kamata, Yasuhisa Fujii. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study. Diagnostics (Basel). 2021.12; 11 (12): 2277. ( PubMed, DOI )

  14. Minato Yokoyama, Junichiro Ishioka, Mikayo Toba, Hiroshi Fukushima, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Masumi Ai, Kiyohide Fushimi, Yasuhisa Fujii. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018. Int J Urol. 2021.12; 28 (12): 1268-1272. ( PubMed, DOI )

  15. Wataru Shimada, Hajime Tanaka, Yuki Fukawa, Koichiro Kimura, Kouhei Yamamoto, Shohei Fukuda, Hiroshi Fukushima, Yosuke Yasuda, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. Int J Urol. 2021.12; 28 (12): 1233-1239. ( PubMed, DOI )

  16. Minato Yokoyama. Editorial Comment from Dr Yokoyama to Partial versus radical nephrectomy in clinical T2 renal masses. Int J Urol. 2021.11; 28 (11): 1155. ( PubMed, DOI )

  17. Shimpei Yamamoto, Soichiro Yoshida, Chikako Ishii, Taro Takahara, Yuki Arita, Hiroshi Fukushima, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. J Magn Reson Imaging. 2021.08; 54 (2): 401-408. ( PubMed, DOI )

  18. Masaki Kobayashi, Junichiro Ishioka, Yoh Matsuoka, Yuichi Fukuda, Yusuke Kohno, Keizo Kawano, Shinji Morimoto, Rie Muta, Motohiro Fujiwara, Naoko Kawamura, Tetsuo Okuno, Soichiro Yoshida, Minato Yokoyama, Rumi Suda, Ryota Saiki, Kenji Suzuki, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray. BMC Urol. 2021.08; 21 (1): 102. ( PubMed, DOI )

  19. Kazutaka Saito, Yoh Matsuoka, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Kazunori Kihara, Yasuhisa Fujii. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer. Brachytherapy. 2021.08; 20 (4): 842-848. ( PubMed, DOI )

  20. Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy. Int Urol Nephrol. 2021.06; 53 (6): 1119-1125. ( PubMed, DOI )

  21. Toshiki Kijima, Hiroshi Fukushima, Shota Kusuhara, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Yasuyuki Sakai, Kazutaka Saito, Nobuaki Matsubara, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clin Genitourin Cancer. 2021.06; 19 (3): 208-216.e1. ( PubMed, DOI )

  22. Yosuke Yasuda, Kazutaka Saito, Hajime Tanaka, Sho Uehara, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. Int J Urol. 2021.03; 28 (3): 302-307. ( PubMed, DOI )

  23. Toshiki Kijima, Hina Yamamoto, Kazutaka Saito, Shota Kusuhara, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Yasuyuki Sakai, Nobuaki Matsubara, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer Immunol Immunother. 2021.03; 70 (3): 657-665. ( PubMed, DOI )

  24. Shohei Fukuda, Kazutaka Saito, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Yukio Kageyama, Yasuhisa Fujii. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. J Immunother Cancer. 2021.02; 9 (2): ( PubMed, DOI )

  25. Soichiro Yoshida, Taro Takahara, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? Int J Urol. 2021.02; 28 (2): 241-242. ( PubMed, DOI )

  26. Yoh Matsuoka, Sho Uehara, Soichiro Yoshida, Hajime Tanaka, Minato Yokoyama, Yasuhisa Fujii. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems. Int J Urol. 2021.01; 28 (1): 127-129. ( PubMed, DOI )

  27. Hiroshi Fukushima, Toshiki Kijima, Shohei Fukuda, Shingo Moriyama, Sho Uehara, Yosuke Yasuda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Nobuaki Matsubara, Noboru Numao, Yasuyuki Sakai, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer Med. 2020.11; 9 (22): 8355-8363. ( PubMed, DOI )

  28. Minato Yokoyama, Hitoshi Masuda, Masaya Ito, Yuma Waseda, Shingo Moriyama, Masahiro Toide, Yusuke Uchida, Sho Uehara, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation. Low Urin Tract Symptoms. 2020.09; 12 (3): 240-244. ( PubMed, DOI )

  29. Ishii A, Yokoyama M, Tsuji H, Fujii Y, Tamaoka A. Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis eNeurologicalSci. 2020.04;

  30. Waseda Y, Kobayashi S, Kanda E, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model Clin Genitourin Cancer. 2020.04;

  31. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

  32. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol. 2020 Jul;27(7):599-604. doi: 10.1111/iju.14251.. 2020;

  33. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

  34. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

  35. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

  36. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

  37. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

  38. Ishii A, Yokoyama M, Tsuji H, Fujii Y, Tamaoka A. Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis eNeurologicalSci. 2020;

  39. Kobayashi M, Yokoyama M, Inoue M, Fujii Y. Undifferentiated prostate cancer treated with docetaxel IJU Case Reports. 2020;

  40. SoichiroYoshida1TaroTakahara23ChikakoIshii3YukiArita34YumaWaseda1ToshikiKijima1MinatoYokoyama1JunichiroIshioka1YohMatsuoka1KazutakaSaito1YasuhisaFujii. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

  41. Kawamura N, Yokoyama M, Tanaka H, Nakayama T, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association. 2019.01; ( PubMed, DOI )

  42. Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia internationalis. 2018.10; 1-6. ( PubMed, DOI )

  43. Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.06; 25 (6): 554-560. ( PubMed, DOI )

  44. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed, DOI )

  45. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Noboru Numao, Tomo Kimura, Kosei Kudo, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int.. 2018.05; ( PubMed, DOI )

  46. Yosuke Yasuda, Kazutaka Saito, Takahiko Soma, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, and others. PD07-05 THE OUTCOME OF GASLESS LAPAROSCOPIC SINGLE-PORT CLAMPLESS SUTURELESS PARTIAL NEPHRECTOMY USING THREE-DIMENSIONAL HEAD-MOUNTED DISPLAY the joural of UROLGY. 2018.04;

  47. Kasumi Kaneko, Soichiro Yoshida, Taro Takahara, Shugo Yajima, Tsuyoshi Sakamoto, Thomas Kwee, Yuki Arita, Minato Yokoyama, and others. MP20-18 SEMI-AUTOMATIC SEGMENTATION ANALYSIS OF DIFFUSION-WEIGHTED MRI AS AN IMAGING BIOMARKER FOR HISTOLOGICAL GRADE OF BLADDER CANCER the joural of UROLGY. 2018.04;

  48. Toshiki Kijima, Thomas Prince, Katsuo Mori, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, and others. MP64-14 TARGETING HEAT SHOCK FACTOR 1 SENSITIZES CASTRATION-RESISTANT PROSTATE CANCER CELLS TO HSP90 INHIBITION IN PART BY DESTABILIZING ANDROGEN RECEPTOR SPLICE VARIANTS the joural of UROLGY. 2018.04;

  49. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, and others. MP20-10 DEEP LEARNING WITH A CONVOLUTIONAL NEURAL NETWORK ALGORITHM FOR FULLY AUTOMATED DETECTION OF PROSTATE CANCER USING PRE-BIOPSY MRI the joural of UROLGY. 2018.04;

  50. Minato Yokoyama, Naoko Kawamura, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, and others. MP42-05 ACUTE KIDNEY INJURY AND INTERMEDIATE-TERM RENAL FUNCTION AFTER CLAMPLESS PARTIAL NEPHRECTOMY the joural of UROLGY. 2018.04;

  51. Yosuke Yasuda, Kazutaka Saito, Takahiko Soma, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, and others. PD07-05 THE OUTCOME OF GASLESS LAPAROSCOPIC SINGLE-PORT CLAMPLESS SUTURELESS PARTIAL NEPHRECTOMY USING THREE-DIMENSIONAL HEAD-MOUNTED DISPLAY the joural of UROLGY. 2018.04;

  52. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Yuma Waseda, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, and others. MP20-09 MRI-BASED RISK ASSESSMENT FOR POSTOPERATIVE BIOCHEMICAL RECURRENCE USING THE PROSTATE IMAGING REPORTING AND DATA SYSTEM (PI-RADS) SCORES AND CAPSULAR CONTACT LENGTH the joural of UROLGY. 2018.04;

  53. Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Sho Uehara, Yousuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. MP36-08 A CONVOLUTIONAL NEURAL NETWORKS ALGORITHM FOR DIFFERENTIAL DIAGNOSIS OF FAT-POOR ANGIOMYOLIPOMA AND RENAL CELL CARCINOMA IN ENHANCED CT AND T2-WEIGHTED MAGNETIC RESONANCE IMAGING the joural of UROLGY. 2018.04;

  54. Takuya Adachi, Minato Yokoyama, Yasuhisa Fujii, Yuko Kinowaki, Susumu Kirimura, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. Neuroblastic tumors in young adults as a sequela of malignant neuroblastoma: report of two cases. Abdom Radiol (NY). 2018.04; ( PubMed, DOI )

  55. Yosuke Yasuda, Kazutaka Saito, Takahiko Soma, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii . PD07-05 THE OUTCOME OF GASLESS LAPAROSCOPIC SINGLE-PORT CLAMPLESS SUTURELESS PARTIAL NEPHRECTOMY USING THREE-DIMENSIONAL HEAD-MOUNTED DISPLAY 2018.04;

  56. shugo yajima, Soichiro Yoshida、 Taro Takahara Minato Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii . MP08-03 ABSENCE OF INCHWORM SIGN ON DWI: A PREDICTIVE MARKER FOR PROGRESSION IN PT1 BLADDER CANCER the joural of UROLGY. 2018.04;

  57. Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

  58. Yasuhiro Kaiho, Hitoshi Masuda, Mineo Takei, Takahiro Hirayama, Takahiko Mitsui, Minato Yokoyama, Takeya Kitta, Naoki Kawamorita, Haruo Nakagawa, Masatsugu Iwamura, Yoichi Arai. Surgical and Patient Reported Outcomes of Artificial Urinary Sphincter Implantation: A Multicenter, Prospective, Observational Study. J. Urol.. 2018.01; 199 (1): 245-250. ( PubMed, DOI )

  59. Yosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, Sho Uehara, Naoko Kawamura, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Shinya Yamamoto, Tetsuo Okuno, Junji Yonese, Kazunori Kihara, Yasuhisa Fujii. Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int. J. Clin. Oncol.. 2017.12; 22 (6): 1081-1086. ( PubMed, DOI )

  60. Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed, DOI )

  61. Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

  62. Minato Yokoyama. Editorial Comment to Outcomes of artificial urinary sphincter placement in octogenarians. Int. J. Urol.. 2016.05; 23 (5): 423-424. ( PubMed, DOI )

  63. Naoko Kawamura, Minato Yokoyama, Yasuhisa Fujii, Junichiro Ishioka, Noboru Numao, Yoh Matsuoka, Kazutaka Saito, Chizuru Arisawa, Tetsuo Okuno, Akira Noro, Shinji Morimoto, Kazunori Kihara. Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal study. Int. J. Urol.. 2016.03; 23 (3): 219-223. ( PubMed, DOI )

  64. Madoka Kataoka, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Nobuaki Funata, Toru Motoi, Ken-Ichi Tobisu, Fumitaka Koga. Retroperitoneal Teratoma in an Adult: A Potential Pitfall in the Differential Diagnosis of Adrenal Myelolipoma. Case Rep Urol. 2016; 2016 5141769. ( PubMed, DOI )

  65. Masaharu Inoue, Yasuhisa Fujii, Minato Yokoyama, Kazutaka Saito, Noboru Numao, Kazunori Kihara. Progression of hypertension after partial nephrectomy in patients with renal tumors: A preliminary report. Int. J. Urol.. 2015.08; 22 (8): 797-798. ( PubMed, DOI )

  66. Kazunori Kihara, Fumitaka Koga, Yasuhisa Fujii, Hitoshi Masuda, Manabu Tatokoro, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Junichiro Ishioka, Kazutaka Saito. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy for peripheral renal tumors: perioperative outcomes. Int. J. Urol.. 2015.04; 22 (4): 349-355. ( PubMed, DOI )

  67. Soichiro Yoshida, Masaya Ito, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Multitask Imaging Monitor for Surgical Navigation: Combination of Touchless Interface and Head-Mounted Display. Urol. Int.. 2015.04; ( PubMed, DOI )

  68. Masaya Ito, Kazunori Kihara, Soichiro Yoshida, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display Urology Case Reports. 2015.03; 3 (2): 27-29. ( DOI )

  69. Junichiro Ishioka, Hitoshi Masuda, Toshiki Kijima, Manabu Tatokoro, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii, Yasuyuki Sakai, Chizuru Arisawa, Tetsuo Okuno, Katsuhi Nagahama, Shigeyoshi Kamata, Junji Yonese, Yukio Kageyama, Akira Noro, Shinji Morimoto, Toshihiko Tsujii, Satoshi Kitahara, Shuichi Gotoh, Kazunori Kihara. Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer Res.. 2014.10; 34 (10): 5683-5688. ( PubMed )

  70. Koga Fumitaka, Kobayashi Shuichiro, Fujii Yasuhisa, Ishioka Junichiro, Yokoyama Minato, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori. Significance of positive urine cytology on progression and cancer-specific mortality of non--muscle-invasive bladder cancer. Clin Genitourin Cancer. 2014.06; 12 (3): e87-e93. ( PubMed, DOI )

  71. Yokoyama Minato, Fujii Yasuhisa, Takeshita Hideki, Kawamura Naoko, Nakayama Takayuki, Iimura Yasumasa, Sakura Mizuaki, Ishioka Junichiro, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Noro Akira, Arisawa Chizuru, Kitahara Satoshi, Kihara Kazunori. Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients. Int J Urol. 2014.03; 21 (3): 238-242. ( PubMed, DOI )

  72. Ishioka Junichiro, Saito Kazutaka, Kijima Toshiki, Nakanishi Yasukazu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Sakura Mizuaki, Yonese Junji, Morimoto Shinji, Noro Akira, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Higashi Yotsuo, Kihara Kazunori. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2014.02; ( PubMed, DOI )

  73. Kobayashi Shuichiro, Fujii Yasuhisa, Koga Fumitaka, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori. Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study. Urol Oncol. 2014.01; 32 (1): 38.e29-38.e36. ( PubMed, DOI )

  74. Yokoyama Minato, Masuda Hitoshi, Kihara Kazunori. Negative pressure wound therapy for surgical site infection associated with artificial urinary sphincter implantation. Int J Urol. 2013.10; 20 (10): 1049-1050. ( PubMed, DOI )

  75. Numao Noboru, Yoshida Soichiro, Komai Yoshinobu, Ishii Chikako, Kagawa Makoto, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. 2013.08; 190 (2): 502-508. ( PubMed, DOI )

  76. Masuda Hitoshi, Kagawa Makoto, Kawakami Satoru, Numao Noboru, Matsuoka Yoh, Yokoyama Minato, Yamamoto Shinya, Yonese Junji, Fukui Iwao, Kihara Kazunori. Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol. 2013.07; 20 (7): 701-707. ( PubMed, DOI )

  77. Manabu Tatokoro, Kazunori Kihara, Hitoshi Masuda, Masaya Ito, Soichiro Yoshida, Toshiki Kijima, Minato Yokoyama, Kazutaka Saito, Fumitaka Koga, Satoru Kawakami, Yasuhisa Fujii. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC Urol. 2013.07; 13 35. ( PubMed, DOI )

  78. Hiroshi Fukushima, Hitoshi Masuda, Minato Yokoyama, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Jpn. J. Clin. Oncol.. 2013.07; 43 (7): 740-746. ( PubMed, DOI )

  79. Hideki Takeshita, Noboru Numao, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Fumitaka Koga, Kazutaka Saito, Hitoshi Masuda, Satoru Kawakami, Shinya Yamamoto, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer. Int Urol Nephrol. 2013.06; 45 (3): 645-652. ( PubMed, DOI )

  80. Masuda Hitoshi, Fukushima Hiroshi, Kawakami Satoru, Numao Noboru, Fujii Yasuhisa, Saito Kazutaka, Koga Fumitaka, Ishioka Junichiro, Yokoyama Minato, Kihara Kazunori. Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage. Jpn J Clin Oncol. 2013.04; 43 (4): 410-416. ( PubMed, DOI )

  81. Kijima Toshiki, Fujii Yasuhisa, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. BJU Int. 2012.10; 110 (8): 1149-1155. ( PubMed, DOI )

  82. Koga Fumitaka, Fujii Yasuhisa, Masuda Hitoshi, Numao Noboru, Yokoyama Minato, Ishioka Jun-ichiro, Saito Kazutaka, Kawakami Satoru, Kihara Kazunori. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches. BJU Int. 2012.09; 110 (6 Pt B): E203-E208. ( PubMed, DOI )

  83. Kijima Toshiki, Masuda Hitoshi, Yoshida Soichiro, Tatokoro Manabu, Yokoyama Minato, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Kihara Kazunori. Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients. Urology. 2012.09; 80 (3): 570-575. ( PubMed, DOI )

  84. Takeshita Hideki, Yokoyama Minato, Fujii Yasuhisa, Chiba Koji, Ishioka Junichiro, Noro Akira, Kihara Kazunori. Impact of renal function on cardiovascular events in patients undergoing radical nephrectomy for renal cancer. Int J Urol. 2012.08; 19 (8): 722-728. ( PubMed, DOI )

  85. Koga Fumitaka, Kihara Kazunori, Yoshida Soichiro, Yokoyama Minato, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int. 2012.03; 109 (6): 860-866. ( PubMed, DOI )

  86. Kobayashi Shuichiro, Koga Fumitaka, Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Komai Yoshinobu, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 2011.10; 21 (10): 2178-2186. ( PubMed, DOI )

  87. Yokoyama M, Fujii Y, Iimura Y, Saito K, Koga F, Masuda H, Kawakami S, Kihara K. Longitudinal change in renal function after radical nephrectomy in Japanese patients with renal cortical tumors. J Urol. 2011.06; 185 (6): 2066-2071. ( PubMed, DOI )

  88. Masuda H, Kawano K, Matsuoka Y, Yokoyama M, Koga F, Saito K, Kihara K, Azuma H. Interactions between inducible nitric oxide synthase and cyclooxygenase-2 in response to ischaemia-reperfusion of rabbit bladder. BJU Int. 2010.09; 106 (5): 716-722. ( PubMed, DOI )

  89. Masuda H, Ichiyanagi N, Yokoyama M, Sakai Y, Kihara K, Chancellor MB, de Groat WC, Yoshimura N. Muscarinic receptor activation in the lumbosacral spinal cord ameliorates bladder irritation in rat cystitis models. BJU Int. 2009.11; 104 (10): 1531-1537. ( PubMed, DOI )

  90. Sakura M, Masuda H, Matsuoka Y, Yokoyama M, Kawakami S, Kihara K. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats. BJU Int. 2009.01; 103 (2): 264-269. ( PubMed, DOI )

  91. Yokoyama M, Fujii Y, Yoshida S, Saito K, Koga F, Masuda H, Kobayashi T, Kawakami S, Kihara K. Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int J Urol. 2009.01; 16 (1): 61-63. ( PubMed, DOI )

  92. Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008.08; 72 (2): 384-388. ( PubMed, DOI )

  93. Yoshida S, Fujii Y, Yokoyama M, Ishii C, Saito K, Koga F, Masuda H, Kobayashi T, Kawakami S, Kihara K. Female urethral diverticular abscess clearly depicted by diffusion-weighted magnetic resonance imaging. Int J Urol. 2008.05; 15 (5): 460-461. ( PubMed, DOI )

  94. Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008.04; 101 (8): 978-981. ( PubMed, DOI )

  95. Matsuoka Y, Masuda H, Yokoyama M, Kihara K. Protective effects of bilirubin against cyclophosphamide induced hemorrhagic cystitis in rats. J Urol. 2008.03; 179 (3): 1160-1166. ( PubMed, DOI )

  96. Matsuoka Y, Masuda H, Yokoyama M, Kihara K. Protective effects of heme oxygenase-1 against cyclophosphamide-induced haemorrhagic cystitis in rats. BJU Int. 2007.12; 100 (6): 1402-1408. ( PubMed, DOI )

  97. Numao N, Kawakami S, Yokoyama M, Yonese J, Arisawa C, Ishikawa Y, Ando M, Fukui I, Kihara K. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol. 2007.12; 52 (6): 1663-1668. ( PubMed, DOI )

  98. Yoshida S, Masuda H, Yokoyama M, Kobayashi T, Kawakami S, Kihara K. Absence of prophylactic antibiotics in minimum incision endoscopic urological surgery (MEUS) of adrenal and renal tumors. Int J Urol. 2007.05; 14 (5): 384-387. ( PubMed, DOI )

  99. Yokoyama M, Arisawa C, Ando M. Successful management of vesicouterine fistula by luteinizing hormone-releasing hormone analog. Int J Urol. 2006.04; 13 (4): 457-459. ( PubMed, DOI )

  100. Kageyama Y, Yokoyama M, Sakai Y, Saito K, Koga F, Yano M, Arai G, Hyochi N, Masuda H, Fujii Y, Kawakami S, Kobayashi T, Kihara K. Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer. Am J Clin Oncol. 2003.10; 26 (5): 504-507. ( PubMed, DOI )

  101. Yokoyama M, Fujii Y, Okuno T, Kawakami S, Kobayashi T, Masuda H, Kageyama Y, Kihara K. Adenocarcinoma arising at the ileoileal anastomotic site of Scheele's ring. Int J Urol. 2003.09; 10 (9): 495-497. ( PubMed )

  102. Kageyama Y, Kihara K, Yokoyama M, Sakai Y, Koga F, Saito K, Yano M, Arai G, Hyochi N, Masuda H, Fujii Y, Kawakami S, Kobayashi T. Endoscopic minilaparotomy partial nephrectomy for solitary renal cell carcinoma smaller than 4 cm. Jpn J Clin Oncol. 2002.10; 32 (10): 417-421. ( PubMed )

▼display all

Books etc 【 display / non-display

  1. Kazunori Kihara, Yasuhisa Fujii, Kazutaka Saito, Fumitaka Koga, Noboru Numao, Yoh Matsuoka, Junichiro Ishioka, Minato Yokoyama, Hitoshi Masuda, Tatsuya Nagai, Soichiro Yoshida, Manabu Tatokoro, Toshiki Kijima, Naoko Kawamura, Masaharu Inoue, Masaya Ito. Gasless Single-Port RoboSurgeon Surgery in Urology. Springer, 2015.09 (ISBN : 978-4-431-54504-0)

Conference Activities & Talks 【 display / non-display

  1. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  2. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  3. Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

  4. 福島啓司、木島敏樹、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、斎藤一隆、松原伸晃、湯浅健、増田均、米瀬淳二、影山幸雄、藤井靖久. 進行尿路上皮癌症例におけるペムブロリズマブの治療効果及び予後:化学放射線療法の治療歴との関連. 第108回 日本泌尿器科学会総会 2020.12.24

  5. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

  6. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  7. Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  8. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target sampling in addition to intra-target sampling for the detection of prostate cancer upgrading according to PIRADS scores. 12th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2020.02.09 Washington DC, USA

  9. Matsumoto S, Yoshida S, Yamada I, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Tateishi U, Fujii Y. Utility of diffusion-weighted MRI radiomics features in differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  10. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  11. Yoshida S, Takahara T, Ishii C, Nakagawa K, Toda K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  12. Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  13. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores near targets are of value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction.. The 12th international symposium on focal therapy and imaging in prostate and kidney cancer, 2020 2020 Washington DC, USA

  14. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores apart from targets are of limited value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  15. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores away from targets are of limited value for the detection of significant cancer: Analysis of 3D prostate biopsy mapping using multiplanar MRI reconstruction.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  16. Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  17. Ito T, Yoshida S, Taniguchi N, Sugimoto M, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. The utility of mixed reality model projection in ultrasound training for medical students.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  18. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  19. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: a multi-institutional study.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  20. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Novel classification model of tumour shape irregularity: significance for predicting potential oncologic risks in clinically localised renal cell carcinoma. The 35th Annual Congress of the European Association of Urology, 2020 (Virtual) 2020

  21. Moriyama S, Yokoyama M, Nakamura Y, Fukuda S, Fukushima H, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of nocturia on deteriorated renal function after adrenalectomy in patients with primary aldosteronism. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  22. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing’s syndrome. The 35th Annual European Association of Urology Congress Virtual, July 2020 2020

  23. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Significance of tumor shape irregularity for predicting potential oncologic risks in clinically localized renal cell carcinoma. The 114th Annual Meeting of the American Urological Association, 2020 (Virtual) 2020

  24. Fukushima H, Kijima T, Uehara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Previous chemoradiotherapy may enhance the efficacy of pembrolizumab in advanced urothelial carcinoma patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  25. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal change in urinary incontinence, lower urinary tract symptoms and quality of life after artificial urinary sphincter implantation. 114th annual meeting of the American Urological Association 2020 Washington DC, USA

  26. Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Low incidence of perioperative infections without antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: a prospective single-institutional study of 1339 patients. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  27. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  28. Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Abe Y, Takemura Y, Fujii Y. Relationship between nocturia and whole-body fluid distribution assessed by bioelectrical impedance. The 115th annual meeting of the American Urological Association 2020

  29. Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility of non-use of antimicrobial prophylaxis in clean urologic surgeries for adrenal and renal tumors: A prospective single-institutional study of 1339 patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam Netherlands

  30. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: A multi-institutional study. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  31. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. 113th annual meeting of the American Urological Association 2019.05.06 Chicago, USA.

  32. Matsuoka Y, Tanaka H,Kimura T, Moriyama S, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M,Ishioka J, Saito K, Fujii Y.. Usefulness of apparent diffusion coefficient ratio between tumor andnontumor as an imaging biomarker for prostate cancer.. The 114th annual meeting of the AmericanUrological Association, 2019.05.06 Chicago, USA

  33. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.Matsuoka Y., Saito K., Fujii Y. ,. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosisin muscle-invasive bladder cancer patients treated with chemoradiation-basedbladder sparing protocol.. 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  34. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Impact of bladder neck involvement and positive urine cytology in substratifying intermediate-risk non-muscle-invasive bladder cancer patients based on the prediction of high-risk recurrence. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  35. Matsuoka Y, Uehara S, Yoshida S, Tanabe K, Tanaka H, Kimura T, Moriyama S,Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who benefits additionally from concurrent systematic biopsy at the time ofMRI-ultrasound fusion targeted biopsy to detect significant prostate cancer?. The 114th annual meeting of the American Urological Association 2019.05.04 Chicago,USA

  36. Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y.. Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA.

  37. 木島敏樹, 森山真吾, 福田翔平, 上原翔, 安田庸輔, 吉田宗一郎横山みなと, 石岡準一郎, 松岡陽, 齋藤一隆, 木原和徳, 藤井靖久.,. 副腎皮質癌の治療成績:再発例に対する集学的治療(化学療法、放射線療法、再発巣切除)の有効性. . 第107回日本泌尿器科学会総会 2019.04.18 名古屋

  38. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.,Matsuoka Y., Saito K., Fujii Y.. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder sparing protocol. . The 34th Annual Congress of the EuropeanAssociation of Urology 2019.03.18 Barcelona, Spain

  39. Fukushima H., Saito K., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Kihara K., Koga F., Okuno T., Arisawa C., Kamata S., Nagahama K., Masuda H., Yonese J., Kageyama Y., Noro A., Tsujii T., Morimoto S., Fujii Y. . Obesity-specific effect of sex on prognosis of upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy: A Japanese multicenter study. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  40. Fukushima H., Saito K., Yasuda Y., Tanabe K., Toide M., Fukuda S., Yokoyama M., Ishioka J., Matsuoka Y., Patil D., Cotta B., Patel S., Master V., Derweesh I., Fujii Y.. Impact of sex on prognosis of non-metastatic clear cell renal cell carcinoma patients undergoing curative surgery: An inverse probability of treatment weighting analysis. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  41. Fukushima H., Kijima T., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Tetra-modality bladder sparing therapy can be a viable treatment option for muscle-invasive bladder cancer patients with sarcopenia. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  42. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.,Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Clinical outcomes of muscle-invasive bladder cancer patients withhydronephrosis treated with tetramodality bladder sparing therapyincorporating consolidative partial cystectomy. . The34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain

  43. Uchida Y., Yoshida S., ShimodaH., TanakaH., SakamotoT., UeharaS., YasudaY.,KijimaT., YokoyamaM., IshiokaJ., MatsuokaY., SaitoK., Fujii Y.. Differentiation of chromophobe renal cell carcinoma and renal oncocytomawith whole-lesion ADC analysis on diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  44. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Substratification of intermediate-risk non-muscle-invasive bladder cancer based on the prediction of high-risk recurrence: Impact of bladder neck involvement and positive urine cytology. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  45. Kasumi Kaneko, Soichiro Yoshida, Yuki Arita, Kouhei Yamamoto, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain.

  46. Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y. . Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  47. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  48. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y.. Loco-regional radiotherapy targeting oligo-progressive lesions in castration-resistant prostate cancer patients: Intra-pelvic localized progressive lesions are the good targets. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  49. Matsuoka Y, Uehara S, Yoshida S, tanabe K, Tanaka H, KimuraT, Moriyama S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who gains additional benefits from systematic biopsy concurrently performedwith MRI-ultrasound fusion targeted biopsy in the detection of significantprostate cancer?. he 34th Annual Congress of the European Association of Urology, 2019.03.16 Barcelona, Spain

  50. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.. Clinical outcomes of muscle-invasive bladder cancer patients with. Genitourinary Cancers Symposium 2019.02.15 San Francisco, USA

  51. 木島敏樹、安田庸輔、上原翔、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. 筋層浸潤膀胱癌に対する4者併用膀胱温存療法(TUR+低用量化学放射線療法+膀胱部分切除):Histologic variantを有する症例での検討.. 日本泌尿器腫瘍研究会第4回学術集会 2018.10.20 横浜

  52. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. The role of MRI-targeted biopsy in prediction of adverse pathologicaland oncological outcome after radical prostatectomy. The 114th annual meeting of the American Urological Association 2018.05.20 San Francisco

  53. Kijima T., Prince T., Yoshida S., Yokoyama M, Ishioka J., Matsuoka. Novel therapy targeting androgen receptor splice variants by inhibiting heat. 112nd annual meeting of the American Urological Association 2018.05.20 San Francisco, USA

  54. Yokoyama M, Kawamura N, Uehara S, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy.. The 113rd annual meeting of the American Urological Association 2018.05.19 San Francisco, USA

  55. 1 Yasuda Y, Saito K, Soma T, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. The outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. he outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. The 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  56. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Fujii Y. MRI-based risk assessment for postoperative biochemical recurrenceusing the Prostate Imaging Reporting and Data System (PI-RADS) scoresand capsular contact length. The 114th annual meeting of the American Urological Association 2018.05.18 San Francisco

  57. Junichiro Ishioka*, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Tomo Kimura, Kosei Kudo,Itsuo Kumazawa, Yasuhisa Fujii. Deep learning with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  58. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Clinical significance of MRI-targeted biopsy for the risk stratification of oncological outcome after radical prostatectomy. 第106回日本泌尿器科学会総会 2018.04.19 京都

  59. 木島 敏樹, 吉田 宗一郎, 横山みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久.. 熱ショック因子(Heat shock factor 1: HSF1)阻害によるARスプライスバリアントを標的とした去勢抵抗性前立腺癌に対する新規治療.. 第106回日本泌尿器科学会総会 2018.04.19 京都

  60. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. The 33th European Association of Urology annual congress 2018.03.26 Copenhagen, Denmark

  61. Yajima S, Yoshida S, Takahara T,Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. The 18th annual meeting of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  62. Yoshida S., Takahara T., Ishii C., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y. 935 METastasis Reporting And Data System for Prostate cancer (MET-RADS-P) score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. The 33th Annual Congress of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  63. Yajima S, Yoshida S, Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  64. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  65. Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. . Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  66. Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  67. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  68. Yoshida S, Takahara T, Ishii C, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . METastasis reporting and data system for prostate cancer score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  69. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  70. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  71. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  72. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  73. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  74. Soma T, Yoshida S, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . The usefulness of diffusion-weighted MRI in the differential diagnosis of urachal disorders. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  75. Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Favorable locoregional control in patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy with lymph node dissection. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.18 Denmark

  76. Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.17 Denmark

  77. Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Kimura T, Kudo K, Kumazawa I, Fujii Y. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.16 Denmark

  78. Yuma Waseda, Kazutaka Saito, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Predictive ability of renal cortex enhancement in dynamic CT for residual renal function after nephroureterectomy: Comparative study with renography.. AUA Annual Meeting 2017 2017.05.15 Boston

  79. Inoue M, Fujii Y, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K.. Incidence and risk factors of postoperative hypertension after partial nephrectomy for renal tumors. AUA Annual Meeting 2017 2017.05.14 Boston

  80. Yuma Waseda, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. New predictive scoring model for recurrence incorporating bladder neck involvement in patients with non-muscle-invasive bladder cancer.. AUA Annual Meeting 2017 2017.05.13 Boston

  81. Yosuke Yasuda1, Kazutaka Saito1, Naoko Kawamura1, Sho Uehara2, Takeshi Yuasa2, Minato Yokoyama1, Junichiro Ishioka1, Yoh Matsuoka1, Shinya Yamamoto2, Shunji Takahashi3, Tetsuo Okuno4, Junji Yonese2, Kazunori Kihara1 and Yasuhisa Fujii1. EARLY RESPONSE AT FOUR WEEKS OF C-REACTIVE PROTEIN PREDICTS SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS. 2017.05.12 Boston

  82. Yokoyama Minato, Koga Fumitaka, Otsuka Yukihiro,Tsukamoto Tetsuro, Okuno Tetsuo, Nagahama Katsushi, Kageyama Yukio, NoroAkira, Tsujii Toshihiko, Morimoto Shinji, Kitahara Satoshi, Kihara Kazunori,and Fujii Yasuhisa. Impact of chronic kidney disease and hypertension ondecline in remaining kidney function after radical nephrectomy. AUA Annual Meeting 2017 2017.05.01 Boston, USA

  83. Yokoyama Minato, Koga Fumitaka, Otsuka Yukihiro,Tsukamoto Tetsuro, Okuno Tetsuo, Nagahama Katsushi, Kageyama Yukio, NoroAkira, Tsujii Toshihiko, Morimoto Shinji, Kitahara Satoshi, Kihara Kazunori,Fujii Yasuhisa. Significance of decreased preoperative estimatedglomerular filtration rate and hypertension on decline in remaining kidney function after radical nephrectomy. 第105回日本泌尿器科学会総会 2017.04.22 鹿児島

  84. 井上雅晴,井靖久,藤将也,木島敏樹,田宗一郎,横山みなと,石岡淳一郎,松岡 陽,齋藤一隆,木原和徳. 腎部分切除後の高血圧発症・増悪およびそのリスク因子. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  85. 田中一,吉田宗一郎,井上雅晴,伊藤将也,木島敏樹,横山みなと,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 膀胱癌の免疫組織化学染色に基づく分子サブタイプ分類と化学放射線療法感受性及び予後の解析:筋層浸潤膀胱癌に対する新たな治療戦略に向けて. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  86. 川村尚子,横山みなと,中山貴之,田中一,井上雅晴,伊藤将也,木島敏樹,吉田宗一郎,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 無阻血腎部分切除後の急性腎障害:発生率と術後腎機能への影響. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島、日本

  87. 吉田宗一郎、高原太郎、石井千佳子、田中一、井上雅晴、伊藤将也、木島敏樹、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  88. Matsuoka Y, Tanaka H, Kimura T, Ito M, Inoue M, Kijima T, Yoshida S,. MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical recurrence after radical prostatectomy. 第105回日本泌尿器科学会総会 2017.04.21 Kagoshima

  89. Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

  90. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London

  91. N. Kawamura, K. Saito, M. Inoue, M. Ito, T. Kijima, S. Yoshida,M. Yokoyama, J. Ishioka, Y. Matsuoka, K. Kihara, Y. Fujii. Adherent perinephric fat in Asian patients: predictors, andimpact on perioperative outcomes of partial nephrectomy. 32nd Annual EAU Congress 2017.03.27 London、England

  92. N. Kawamura, M. Yokoyama, T. Nakayama, H. Tanaka, M. Inoue, M.Ito, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, K. Saito, K. Kihara,Fujii Y.. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction . 32nd Annual EAU Congress 2017.03.27 London、England

  93. Matsuoka Y, Saito K, Numao N, Tanaka H, Inoue M, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Risk assessment for undertreatment in focal therapy and its applicability to intermediate- and high-risk prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  94. Saito K, Matsuoka Y, Numao N, Hayashi K, Toda K, Ito M, Inoue M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Hemi-gland brachytherapy for localized prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  95. 13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San diego, USA

  96. Matsuoka Y et al. Impact of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) on the assessment of extracapsular extension in prostate cancer: A multireader study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 USA

  97. Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San diego, USA

  98. Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

  99. 8.Ishioka J et al. Yokoyama M., Kawamura N., Fujii Y., Inoue M., Ishioka J., Numao N., Matsuoka Y., Saito K., Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K.. Longitudinal renal function recovery after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San diego, USA

  100. Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 USA

  101. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San diego, USA

  102. Matsuoka Y et al. Impact of prebiopsy magnetic resonance imaging (MRI) on preoperative risk stratification for biochemical recurrence after radical prostatectomy. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 USA

  103. Yoshida S et al. . Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  104. Fujiwara M et al.. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  105. Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  106. Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07

  107. Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA,

  108. 21.Nakanishi Y, Fukushima H, Yokoyama M, Kataoka M, Tobisu K, Koga F. Can systematic biopsy be safely omitted in the era of MRI/TRUS-fusion targeted prostate biopsy?. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  109. Matsuoka Y et al. Applicability analysis of focal therapy to intermediate- and high-risk prostate cancer. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 USA

  110. Nakamura Y et al. . High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  111. Nakamura Y et al.. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  112. Ishioka J et al.. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  113. Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  114. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  115. 4.Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K.. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  116. Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  117. 14.Yasuda Y, Saito K, Kawamura N, Yuasa T, Yokoyama M, Matsuoka Y, Ishioka J, Numao N, Okuno T, Yamamoto S, Takahashi S, Yonese J, Fujii Y, Kihara K. Prognostic significance of early CRP response for metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  118. Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

  119. 1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Germany

  120. 5.Yokoyama M, Kawamura N, Fujii Y, Inoue M, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K. . Longitudinal changes in renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter study using a linear mixed model analysis. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Germany

  121. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  122. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  123. Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13

  124. Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  125. Yoshida S et al. . Potential utility of standardized apparent diffusion coefficient value as a biomarker predicting clinical aggressiveness of bladder cancer with various MRI protocols at various institutions. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  126. Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  127. Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

  128. Saito K, Matsuoka Y, Numao N, Hayashi K, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Focal therapy for prostate cancer with hemi-gland low dose rate brachytherapy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam

  129. Matsuoka Y, Numao N, Saito K, Tanaka H, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Eligibility analysis for focal therapy based on prostatectomy findings: Does intermediate-risk cancer have a higher likelihood of undertreatment than low-risk cancer?. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  130. Numao N, Ito M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Efficient sampling methods in systematic biopsy that could be performed in combination with MRI-guided biopsy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  131. Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Recovery in renal function after radical nephrectomy and its negative predictive factors: a multicenter longitudinal study. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  132. Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S.m Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  133. Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal MRI-targeted biopsy sampling number. The 111th annual meeting of the American Urological Association 2015.05.17

  134. Fujii, Y., Moriyama S., Yokoyama M., Yonese J., Noro A., Arisawa C., Morimoto S., Okuno T., Kitahara S., Koga F., Sakai Y., Suzuki M., Nagahama K., Izutani T., Saito K., Kihara K, TMDU NMIBC group.. Impact of bladder neck involvement on progression in patients with primary non-muscle-invasive bladder cancer: A multicenter validation study. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA

  135. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative selection algorithm for eligible neoadjuvant chemotherapy patients in upper tract urothelial carcinomas. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  136. Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  137. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Yokoyama M, Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. A novel three-dimensional image display system for transurethral surgery. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  138. 2.Ishioka J, Yokoyama M, Waseda Y,Kawamura N, Itoh M, Tatokoro M, Yoshida S, Matsuoka Y,Numao N, Saito K, Arisawa C, Morimoto S, Kageyama Y,Fujii Y, Kihara K. Preoperative prediction of postoperative renal function for upper tract urothelial carcinoma patients: Concerning issues of perioperative renal impairment and the use of cisplatin-based chemotherapy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  139. 15.Fujii, Y., Moriyama S., Yokoyama M., Yonese J., Noro A., Arisawa C., Morimoto S., Okuno T., Kitahara S., Koga F., Sakai Y., Suzuki M., Nagahama K., Izutani T., Saito K., Kihara K. Bladder neck involvement predicts progression in patients with primary non-muscle-invasive bladder cancer: A multicenter validation study. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  140. 8.Nakamura Y. , Numao N. , Yoshida S. , Komai Y. , Ito M. , Tatokoro M. , Yokoyama M. , Ishioka J. , Matsuoka Y. , Saito K. , Fujii Y. , Kihara K.. Transrectal 12-core prostate biopsy and MRI have a comparable risk of missing significant prostate cancer in men with PSA less than 10ng/ml and normal DRE. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  141. 3.Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Longitudinal change and risk factors of severe deterioration in renal function after radical nephrectomy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  142. 5.Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  143. 14.Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  144. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative prediction algorithm for the selection of candidates for neoadjuvant chemotherapy in upper tract urothelial carcinomas. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  145. 10.Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal number of sampling cores in MRI-targeted biopsy, Madrid. The 30th Annual Congress of the European Association of Urology 2015.03.21 Madrid, Spain

  146. 9.Nakayama T., Saito K., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N, Kihara K. Prognostic comparison of serum biomarkers for cancer-specific survival of renal cell carcinoma undergoing nephrectomy: C-reactive protein has the highest predictive ability on survival. The 30th Annual Congress of the European Association of Urology 2015.03.21

  147. Masaharu Inoue, Yasuhisa Fujii, Minato Yokoyama, Masaya Ito, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Kazunori Kihara. Progression of hypertension after partial nephrectomy in Japanese patients with renal tumors. 30th Annual EAU Congress 2015.03.21 Madrid, Spain

  148. Yokoyama Minato, Fujii Yasuhisa, Inoue Masaharu, Takeshita Hideki, Yoshida Soichiro, Ishioka Junichiro, Numao Noboru, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori.. Does anatomical tumor complexity affect renal function after clampless partial nephrectomy? A functional analysis using renal scintigraphy. (Yokoyama Minato, Fujii Yasuhisa, Inoue Masaharu, Takeshita Hideki, Yoshida Soichiro, Ishioka Junichiro, Numao Noboru, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori.). 34th congress of the SIU 2014.10.13 Glasgow, UK

▼display all